The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age17-39
SponsorUnited States Army Research Institute of Environmental Medicine

About this trial

This longitudinal study will examine the effects of repeated bouts of operational stress and limited recovery on integrated MPS, whole-body protein balance, iron absorption, and aerobic performance. Following baseline characterization measures, active adults (n=24) representative of normal weight phenotype (NW; n=12) and overweight phenotype (OW; n=12) will complete a 48h balance phase preceding two rounds of repeated 72h energy deficit exposure each immediately followed by a 48h recovery phase. NW cutoff will be defined ≤ 22% body fat for males and ≤ 32% body fat for females. OW cutoff will be defined as \>22% body fat for males and \>32% body fat for females. These body composition cutoffs are informed by the maximum allowable percent body fat standards outlined in current Army Regulation 600-9. Additional details for determining % body fat are outlined in the experimental procedures section of the protocol.

Eligibility criteria

Qualifiers

Men and women aged 18 - 39 years (17 - 39 years if military personnel)

Weight stable in the past 2 months (± approximately 5 kg)

Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station medical support (HMS)

Functional exercise (i.e., step ups, box jumps, body mass movements) and/or aerobic exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 months

Disqualifiers

Musculoskeletal injuries that compromise exercise capability as determined by OMSO or HMS

Metabolic or cardiovascular abnormalities, sleep disorders (i.e., sleep apnea) gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.) as determined by OMSO or HMS

Abnormal or problems with blood clotting as determined by OMSO or HMS

History of complications with lidocaine or similar local anesthetic analogue

Trial design

Treatments tested in this trial

  • Operational Stressors

Treatment groups

24 Participants
are divided into 2 treatment groups

Sponsors and collaborators